logo
Zollinger Road in Upper Arlington could see major changes soon

Zollinger Road in Upper Arlington could see major changes soon

Yahoo19-07-2025
Upper Arlington is working on plans to revamp Zollinger Road, which could involve narrowing the roadway and adding bike lines.
However, the city is considering feedback from residents before making a decision on the future of the roadway, City Engineer Aaron Scott said in an interview with The Dispatch. Construction is expected to start in 2027.
'It's one of our larger roadways, one of our bigger collector streets, so we wanted to make sure if we do it, we do it right — and if residents have changes they want to see, we can incorporate those,' Scott said.
Plans to work on Zollinger Road have been in discussion since at least 2016, when the city identified that it would need to be repaved within about a decade. Adding multi-modal improvements could make sense on the roadway, Scott said, but feedback from residents is shaping the future of the project.
The city held a public feedback session in 2022 ahead of submitting a grant application. At the time, one of the largest concerns residents shared was speeding on the road, Scott said. The city also held a public meeting July 10 at the Bob Crane Community Center and is collecting feedback from an interactive map.
Zollinger Road serves as a collector road to help people move from residential streets to larger arterial roads, such as Riverside Drive, Tremont Road and Northwest Boulevard. However, Zollinger Road, which traverses the middle of the city from east to west, is one of the larger collector streets in the city with two lanes in both directions.
The city received over $3.3 million in a grant for construction of the project of federal dollars via the Mid-Ohio Regional Planning Commission, which requires at least a 20% matching fund from the city.
Although some federal funding has been canceled or put in limbo since the start of the Trump administration in January, Scott said construction funding has already been allocated.
While specific changes to the road are still to be determined, the project will include adding streetlights to Zollinger Road between Tremont Road and Riverside Drive — the only segment of the road without lighting.
The northern half of Redding Road is under construction and went through a similar process as Zollinger Road, but the city did not receive any outside funding, Scott said. The city is narrowing the road from a four-lane road to a two-lane road, with one lane traveling in each direction.
Upper Arlington is not immediately working on other plans to revamp other streets in the city, but that could come up in future years as the city identifies roadways that need maintenance, Scott said.
Anna Lynn Winfrey covers the western suburbs for the Columbus Dispatch. She can be reached at awinfrey@dispatch.com.
This article originally appeared on The Columbus Dispatch: Upper Arlington may add bike lanes, cut lanes on Zollinger Road
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SRPT LEGAL ALERT: Lose Money on Your Sarepta Therapeutics, Inc. Investment? Contact BFA Law by August 25 Class Action Deadline (NASDAQ:SRPT)
SRPT LEGAL ALERT: Lose Money on Your Sarepta Therapeutics, Inc. Investment? Contact BFA Law by August 25 Class Action Deadline (NASDAQ:SRPT)

Associated Press

time6 minutes ago

  • Associated Press

SRPT LEGAL ALERT: Lose Money on Your Sarepta Therapeutics, Inc. Investment? Contact BFA Law by August 25 Class Action Deadline (NASDAQ:SRPT)

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Sarepta Therapeutics, Inc. (NASDAQ: SRPT) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Sarepta, you are encouraged to obtain additional information by visiting: Investors have until August 25, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Sarepta securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Dolgicer v. Sarepta Therapeutics, Inc., et al., No. 25-cv-05317. Why Was Sarepta Sued for Securities Fraud? Sarepta is a biopharmaceutical company focused on developing treatments for rare diseases. Sarepta's most important product is Elevidys, a therapy for the treatment of Duchenne muscular dystrophy. As alleged, Sarepta repeatedly touted the safety profile of Elevidys and told investors that the benefits of the treatment outweighed its risks. In truth, Elevidys causes fatal acute liver failure in some patients. The Stock Declines as the Truth Is Revealed On March 18, 2025, Sarepta announced that a patient that had been treated with Elevidys died after suffering acute liver failure. On this news, the price of Sarepta stock fell $27.81 per share, or over 27%, from $101.35 per share on March 17, 2025, to $73.54 per share on March 18, 2025. Nevertheless, on the same day, Sarepta assured investors that 'the benefit-risk of ELEVIDYS remains positive.' Next, on June 15, 2025, Sarepta announced that a second patient treated with Elevidys had died from acute liver failure and that it was suspending certain shipments of Elevidys and paused dosing in an ongoing clinical trial of the treatment. On this news, the price of Sarepta stock fell $15.24 per share, or more than 42%, from $36.18 per share on June 13, 2025, to $20.94 per share on June 16, 2025. Finally, on July 17, 2025, Sarepta revealed that a third patient treated with one of Sarepta's investigational treatments related to Elevidys had died from acute liver failure in June 2025. On this news, the price of Sarepta stock fell more than 40% on July 18, 2025. Click here for more information: What Can You Do? If you invested in Sarepta you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact: Ross Shikowitz [email protected] 212.789.3619 Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.

SJM LEGAL ALERT: Lose Money on Your The J.M. Smucker Co. Investment? Contact BFA Law about its Securities Fraud Investigation (NYSE:SJM)
SJM LEGAL ALERT: Lose Money on Your The J.M. Smucker Co. Investment? Contact BFA Law about its Securities Fraud Investigation (NYSE:SJM)

Associated Press

time6 minutes ago

  • Associated Press

SJM LEGAL ALERT: Lose Money on Your The J.M. Smucker Co. Investment? Contact BFA Law about its Securities Fraud Investigation (NYSE:SJM)

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into The J.M. Smucker Company (NYSE: SJM) for potential violations of the federal securities laws. If you invested in J.M. Smucker, you are encouraged to obtain additional information by visiting: Why Is J.M. Smucker being Investigated? J.M. Smucker manufactures and markets branded food and beverage products. In November 2023, the company completed an acquisition of Hostess Brands, Inc., a manufacturer and marketer of sweet baked goods brands. The company stated that the Hostess acquisition was 'highly complementary' and that 'underlying trends in snacking and specifically sweet snacking still bode well for the category.' In truth, it appears the company's Sweet Baked Snacks segment, which includes Hostess, significantly deteriorated in the face of declining trends in sweet snacking. The Stock Declines as the Truth Is Revealed On June 10, 2025, J.M. Smucker reported its Q4 2025 financial results and announced that it recognized a $867 million impairment charge related to the goodwill of its Sweet Baked Snacks segment and a $113 million impairment charge related to the Hostess brand trademark driven by the 'continued underperformance of the Sweet Baked Snacks segment.' On this news, the price of J.M. Smucker stock fell $17.44 per share, or more than 18%, from $111.85 per share on June 9, 2025, to $94.41 per share on June 10, 2025. Click here for more information: What Can You Do? If you invested in J.M. Smucker you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact: Ross Shikowitz [email protected] 212.789.3619 Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.

Sausage company issues sweeping recall after consumers found foreign objects inside: 'The product is no longer available'
Sausage company issues sweeping recall after consumers found foreign objects inside: 'The product is no longer available'

Yahoo

time8 minutes ago

  • Yahoo

Sausage company issues sweeping recall after consumers found foreign objects inside: 'The product is no longer available'

Sausage company issues sweeping recall after consumers found foreign objects inside: 'The product is no longer available' A sausage company recalled thousands of items because of plastic contamination. What's happening? Kayem Foods found out about the issue when it received three customer complaints, Food Safety News reported. The company contacted the U.S. Department of Agriculture Food Safety and Inspection Service about the white pieces of plastic. The chicken sausages were packaged in 11-ounce sizes and produced June 28. The product is All Natural Al Fresco Sweet Apple Chicken Sausage with Vermont-made syrup. Customers can determine if their purchases are part of the recall by checking the lot code (179), use/freeze by date (Oct. 1), and establishment number (P-7839). The first two identifiers are printed on the package's back label, while the last is printed inside the USDA mark of inspection, per FSN. No injuries were reported. The sausages were shipped from Chelsea, Massachusetts, to locations around the country. Buyers can return the food or throw it away but should not eat it. Why is this important? Plastic contamination is worrisome because it can harm human health. The ubiquity of the material presents problems for the environment and economies as well. Plastic is made from petroleum, a dirty fuel that contributes most of the heat-trapping pollution that is causing the rapid warming of the planet. It also creates mass amounts of waste since, contrary to popular belief, it is not easily recyclable. This means countries lose untold sums from trash that reaches the ocean. The University of Michigan said marine waste can reduce real estate prices by 25%. And it causes up to $2.5 trillion in annual global economic damage, according to the National Caucus of Environmental Legislators, impacting tourism, fishing, and other industries. "FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers," FSN stated. "When available, the retail distribution list(s) will be posted on the FSIS website at What's being done about food contamination? While microplastics are commonly found in food, water, air, and soil, larger pieces of plastic pollutants are less common. They are usually found by USDA or company inspection, though that was not the case here, and government spending cuts could make that more common. Using alternatives to plastic in food production and packaging would reduce this risk. You can help by advocating for policy reform and using less plastic. Call your representatives and bring your own reusable items when you're on the go: a metal water bottle, canvas grocery bags, and stainless steel or glass food containers. Do you think Americans use too much plastic? Absolutely Only in some states We're getting better We're doing fine Click your choice to see results and speak your mind. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store